Search results for "Gate"

showing 10 items of 1811 documents

Analysis of cardiac and pulmonary complication probabilities after radiation therapy for patients with early-stage breast cancer

2009

Objective. The purpose of this study was to evaluate the radiobiological implications of clinical use of respiratory-gated techniques for postoperative radiation therapy of early-stage left-sided breast cancer after breast-conserving surgery. Material and methods. Radiation therapy treatment plans of 80 patients with early-stage breast cancer (stage I–II), receiving whole breast irradiation after breast-conserving therapy, were analyzed. The control group consisting of 47 patients received standard radiation therapy, and the respiratory-gated group consisting of 33 patients received deep inspiration-gated radiation therapy. Normal tissue complication probabilities (NTCP) for cardiac mortali…

medicine.medical_specialtyRespiratory-Gated Imaging TechniquesHeart Diseasesearly-stage breast cancermedicine.medical_treatmentBreast NeoplasmsMastectomy SegmentalStatistics NonparametricCohort StudiesBreast cancerWhole Breast Irradiationnormal tissue complication probabilitymedicineHumansBreastStage (cooking)Radiation Injuriesrespiratory-gated radiotherapyPneumonitisNeoplasm StagingProbabilitybusiness.industryrespiratory-gated radiotherapy; early-stage breast cancer; breast-conserving therapy; normal tissue complication probabilityPatient SelectionRespirationPulmonary ComplicationRadiotherapy DosageGeneral Medicinemedicine.diseaseLatviaSurgeryRadiation therapyRadiation Pneumonitisbreast-conserving therapyFemaleRadiotherapy AdjuvantRadiotherapy ConformalComplicationbusinessTomography X-Ray ComputedMastectomyMedicina
researchProduct

Procalcitonin for the diagnosis of invasive candidiasis: what is the evidence?

2017

Abstracts Procalcitonin is a widely used marker for the evaluation of infection and sepsis and to guide antibiotic therapy. During the last decade, several studies evaluated its role and diagnostic performance as a surrogate marker for the identification of Candida spp. in suspected invasive candidiasis. A low serum level and a favorable negative predictive value are the main findings for procalcitonin in this setting. The aim of this report is to provide an updated brief summary of the evidence supporting the use of PCT for the management of invasive candidiasis.

medicine.medical_specialtySepsiInvasive candidiasiCritical Care and Intensive Care MedicineProcalcitoninSepsis03 medical and health sciences0302 clinical medicineAntibiotic therapySepsismedicine030212 general & internal medicineIntensive care medicineLetter to the EditorCandida spp.Surrogate endpointbusiness.industrylcsh:Medical emergencies. Critical care. Intensive care. First aid030208 emergency & critical care medicineInvasive candidiasislcsh:RC86-88.9medicine.diseasebacterial infections and mycosesCandida spp.; Invasive candidiasis; Procalcitonin; Sepsis; Critical Care and Intensive Care MedicinePredictive valueInvasive candidiasisCandida sppbusinessProcalcitoninhormones hormone substitutes and hormone antagonistsJournal of Intensive Care
researchProduct

A low threshold to ECG-gated repeat CTA reduces the risk of false-positive diagnosis of type A dissection in interhospital referrals: a case series s…

2018

Angela Kornberger,1 Iris Burck,2 Hazem El Beyrouti,1 Nancy Halloum,1 Andres Beiras-Fernandez,1 Christian-Friedrich Vahl1 1Department of Cardiothoracic and Vascular Surgery, University Hospital of Johannes Gutenberg University, Mainz, Germany; 2Department of Diagnostic and Interventional Radiology, University Hospital of Johann Wolfgang Goethe University, Frankfurt am Main, Germany Background: False-positive diagnosis of acute Stanford type A aortic dissection (AAD) on computed tomography angiography (CTA) is still an issue and may lead to substantial consequences. Given that electrocardiography (ECG)-gated CTA provides greater diagnostic safety, it may be assumed that interhospital referral…

medicine.medical_specialtyStanford type A dissectionTherapeutics and Clinical Risk Managementfalse-positive diagnosisECG-gated CTA030204 cardiovascular system & hematology030218 nuclear medicine & medical imaging03 medical and health sciences0302 clinical medicinemedicinePharmacology (medical)Case Seriescardiovascular diseasesGeneral Pharmacology Toxicology and PharmaceuticsType a dissectionComputed tomography angiographyAortic dissectionChemical Health and Safetymedicine.diagnostic_testbusiness.industrymusculoskeletal neural and ocular physiologyGeneral Medicinemedicine.diseaseRadiologybusinessSafety ResearchElectrocardiographypsychological phenomena and processesCase seriesTherapeutics and Clinical Risk Management
researchProduct

Measurement of exhaled nitric oxide: comparison of 3 different analyzers

2018

Exhaled nitric oxide (FeNO) is used as a surrogate marker to monitor airway inflammation. Aim of this study was to compare the new FeNO analyzer Vivatmo pro from Bosch (BV) with the Niox Vero from Circassia (CN) and the CLD from Ecomedics (EC). In 106 asthma patients (median age 54 years (range 20-87), 60 % female, median ACT of 16, 85 % on inhaled corticosteroids (mean 1300 μg BDP), 36 % on therapy with biologics) 2 FeNO measurements per patient and per device were performed using each analyzer in a random sequence according to the ATS / ERS guidelines. Additionally, the success rate to achieve a valid NO value was evaluated. 70 % of the patients had FeNO values In conclusion, for the rang…

medicine.medical_specialtySurrogate endpointbusiness.industryAirway inflammationInhaled corticosteroidsrespiratory systemmedicine.diseaseGastroenterologyrespiratory tract diseasesInternal medicineExhaled nitric oxidemedicinebusinessAsthmaMonitoring Airway Disease
researchProduct

Luspatercept Increases Hemoglobin and Reduces Transfusion Burden in Patients with Low-Intermediate Risk Myelodysplastic Syndromes (MDS): Long-Term Re…

2016

Abstract Background: Management of anemia is a common therapeutic challenge in patients with MDS. Luspatercept (ACE-536), a fusion protein containing modified activin receptor type IIB, is being developed for treatment of anemia in lower-risk MDS. Luspatercept binds GDF11 and other TGF-β superfamily ligands to promote late-stage erythroid differentiation and increase hemoglobin (Hgb) levels (Suragani R, Nat Med, 2014 and Attie K, Am J Hematol, 2014). Aims: This is an ongoing, phase 2, multicenter, open-label, long-term extension study to evaluate the effects of luspatercept in patients (pts) with low-intermediate risk MDS. Endpoints include long-term safety and tolerability, erythroid respo…

medicine.medical_specialtybusiness.industryAnemiaSurrogate endpointMyelodysplastic syndromesImmunologyPhases of clinical researchCell BiologyHematologymedicine.diseaseBiochemistryGastroenterologySurgery03 medical and health sciences0302 clinical medicineTolerability030220 oncology & carcinogenesisPharmacodynamicsInternal medicineMedicinebusinessAdverse effect030215 immunologyLenalidomidemedicine.drugBlood
researchProduct

Pioneer: A Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study of Avapritinib in Patients with Indolent or Smoldering Systemic Mastocytosis w…

2019

Background: The gain-of function mutation KIT D816V plays a central role in the pathogenesis of systemic mastocytosis (SM). Among subtypes of SM, indolent SM (ISM) is the most frequent and is associated with normal/near-normal life expectancy; smoldering SM (SSM) is a subtype with a relatively higher burden of mast cells and may be associated with an increased risk of progression to advanced mastocytosis. However, both ISM and SSM patients may experience severe symptoms associated with mast cell mediator release, such as pruritus, diarrhea, anaphylaxis, and bone pain, which can be severely debilitating and have a profoundly negative impact on quality of life. Symptomatic treatments (eg, ant…

medicine.medical_specialtybusiness.industrySurrogate endpointImmunologyPhases of clinical researchCell BiologyHematologymedicine.diseasePlaceboBiochemistryDouble blindInternal medicineMedicineIn patientSystemic mastocytosismedicine.symptombusinessBone painAsthmaBlood
researchProduct

Recognition and characterization of small colonic neoplasia with high-definition colonoscopy using i-Scan is as precise as chromoendoscopy

2010

Abstract Background The EPKi system (Pentax, Japan) enables resolution above HDTV. Aim of the study was to test the efficacy of HD+ alone and with the new post-processing digital filter i-Scan or chromoendoscopy (Methylene blue 0.1%) in screening for colorectal cancer. We focused on lesions less than 5 mm as a surrogate marker for the optical possibilities of the EPKi system. Methods The last 30 cm of the colon in a screening population were inspected with HD+ alone, in combination with i-Scan (2:1 randomisation) and subsequently with chromoendoscopy. All lesions were characterized and targeted biopsies were performed. Results i-Scan augmented in 69 patients the identification of lesions fr…

medicine.medical_specialtyeducation.field_of_studyHepatologymedicine.diagnostic_testColorectal cancerSurrogate endpointbusiness.industryHigh definition endoscopyPopulationGastroenterologyColonoscopymedicine.diseaseTime efficientChromoendoscopymedicineHigh definitionRadiologyeducationbusinessDigestive and Liver Disease
researchProduct

Subclinical atherosclerosis: independent predictor of cardiovascular events in a 20-years follow up of patients with or without metabolic syndrome

2013

Purpose: To evaluate the influence of carotid atherosclerosis and metabolic syndrome (MetS) on the prediction of cardiovascular events during a 20-years follow-up. Methods: We studied a population of 529 asymptomatic patients, divided into 2 groups according to the results of the carotid ultrasound evaluation: one without atherosclerotic lesions (198 patients) and a second one with an increased carotid IMT or asymptomatic carotid plaque (331 patients). In each of these groups, we identified two subgroups of subjects with and without MetS. Cardiovascular endpoints were investigated in a 20-years follow-up: acute myocardial infarction, angina, transient ischemic attack, ischemic stroke, abdom…

medicine.medical_specialtyeducation.field_of_studybusiness.industrySurrogate endpointmedicine.medical_treatmentPopulationmedicine.diseaseAsymptomaticAbdominal aortic aneurysmAnginaAtherectomyInternal medicinemedicineCardiologyMyocardial infarctionmedicine.symptomMetabolic syndromeCardiology and Cardiovascular MedicinebusinesseducationEuropean Heart Journal
researchProduct

Effects of empagliflozin on CA125 trajectory in patients with chronic congestive heart failure

2021

INTRODUCTION: We aimed to evaluate the trajectory of two surrogates of fluid overload -antigen carbohydrate 125 (CA125) and amino-terminal pro-brain natriuretic peptide (NT-proBNP)- after the addition of oral empagliflozin to usual care in a cohort of patients with chronic heart failure (CHF) and type 2 diabetes (T2D). METHODS AND RESULTS: From October 2015 to February 2019, 60 ambulatory patients with CHF and T2D were retrospectively included. The primary endpoint was to assess the longitudinal trajectory of plasma levels of CA125 and NT-proBNP after empagliflozin initiation. Changes in quantitative variables were evaluated using linear mixed regression. Median CA125 and NT-proBNP at basel…

medicine.medical_specialtyendocrine system diseasesType 2 diabetes030204 cardiovascular system & hematologyCA12503 medical and health sciences0302 clinical medicineGlucosidesEmplagliflozinInterquartile rangeLongitudinal trajectoriesInternal medicineNatriuretic Peptide BrainmedicineEmpagliflozinClinical endpointHumansSGLT2icardiovascular diseases030212 general & internal medicineBenzhydryl CompoundsRetrospective StudiesHeart FailureSurrogate endpointbusiness.industrymedicine.diseasePeptide FragmentsDiabetes Mellitus Type 2Heart failureNTproBNPAmbulatoryCohortCardiologyCardiology and Cardiovascular MedicinebusinessBiomarkersInternational Journal of Cardiology
researchProduct

Randomized clinical trial comparing liver resection with and without perioperative assessment of liver function

2018

Background Liver function tests may help to predict outcomes after liver surgery. The aim of this study was to evaluate the clinical impact on postoperative outcome and patient management of perioperative liver function testing using the LiMAx® test. Methods A multicentre RCT was conducted in six academic liver centres. Patients with intrahepatic tumours scheduled for open liver resection of at least one segment were eligible. Patients were randomized to undergo additional perioperative liver function tests (LiMAx® group) or standard care (control group). Patients in the intervention arm received two perioperative LiMAx® tests, one before the operation for surgical planning and another afte…

medicine.medical_specialtymedicine.diagnostic_testSurrogate endpointbusiness.industryIncidence (epidemiology)General MedicinePerioperative030230 surgeryIntensive care unitlaw.inventionSurgery03 medical and health sciences0302 clinical medicineRandomized controlled triallaw030220 oncology & carcinogenesisClinical endpointmedicineLiver functionLiver function testsbusinessBJS Open
researchProduct